Alzheimer s Disease Clinical Trials in London
7 recruitingLondon, United Kingdom
Showing 1–7 of 7 trials
Recruiting
Phase 1
A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
Alzheimer s Disease
Alnylam Pharmaceuticals50 enrolled13 locationsNCT07214727
Recruiting
Phase 1
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)
Alzheimer s Disease
Hoffmann-La Roche50 enrolled8 locationsNCT07234942
Recruiting
Phase 1Phase 2
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Alzheimer s DiseaseBeta-AmyloidProdromal Alzheimer's Disease+2 more
AC Immune SA304 enrolled26 locationsNCT05462106
Recruiting
Phase 2
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Alzheimer s Disease
Novartis Pharmaceuticals407 enrolled65 locationsNCT07094516
Recruiting
Dominantly Inherited Alzheimer Network (DIAN)
Alzheimer s Disease
Washington University School of Medicine700 enrolled26 locationsNCT00869817
Recruiting
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
Memory DisordersMild Cognitive ImpairmentMemory Impairment+3 more
GAP Innovations, PBC1,200 enrolled26 locationsNCT06584357
Recruiting
Phase 2
Open-label Extension Study in Participants With Early Alzheimer's Disease
Alzheimer s Disease
GlaxoSmithKline220 enrolled33 locationsNCT07105709